MONTANARO, ELISA
Dettaglio
MONTANARO, ELISA
PSICOLOGIA
Pubblicazioni
Risultati 1 - 20 di 27 (tempo di esecuzione: 0.001 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic | 2021 | Montanaro E.; Artusi C.A.; Rosano C.; Boschetto C.; Imbalzano G.; Romagnolo A.; Bozzali M.; Rizzone M.G.; Zibetti M.; Lopiano L. |
2 | Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease | 2021 | Montanaro E.; Romagnolo A.; Fabbri M.; Artusi C.A.; Imbalzano G.; Rizzone M.G.; Lopiano L.; Zibetti M. |
3 | Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders | 2021 | Pilotto, Andrea; Romagnolo, Alberto; Scalvini, Andrea; Masellis, Mario; Shimo, Yasushi; Bonanni, Laura; Camicioli, Richard; Wang, Lily L; Dwivedi, Alok K; Longardner, Katherine; Rodriguez-Porcel, Federico; DiFrancesco, Mark; Vizcarra, Joaquin A; Montanaro, Elisa; Maule, Simona; Lupini, Alessandro; Ojeda-Lopez, Carmen; Black, Sandra E; Pizzi, Stefano Delli; Gee, Myrlene; Tanaka, Ryota; Yamashiro, Kazuo; Hatano, Taku; Borroni, Barbara; Gasparotti, Roberto; Rizzetti, Maria C; Hattori, Nobutaka; Lopiano, Leonardo; Litvan, Irene; Espay, Alberto J; Padovani, Alessandro; Merola, Aristide |
4 | Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors | 2019 | Artusi C.A.; Balestrino R.; Imbalzano G.; Bortolani S.; Montanaro E.; Tuttobene S.; Fabbri M.; Zibetti M.; Lopiano L. |
5 | Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment | 2018 | Romagnolo, Alberto*; Fabbri, Margherita; Merola, Aristide; Montanaro, Elisa; Palermo, Sara; Martone, Tiziana; Seresini, Agostino; Goldwurm, Stefano; Rizzone, Mario Giorgio; Lopiano, Leonardo |
6 | Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study | 2019 | Romagnolo, Alberto*; Zibetti, Maurizio; Merola, Aristide; Canova, Daniela; Sarchioto, Marianna; Montanaro, Elisa; Artusi, Carlo Alberto; Vallelonga, Fabrizio; Maule, Simona; Lopiano, Leonardo |
7 | Complex therapies for advanced Parkinson’s disease: what is the role of doctor-patient communication? | 2019 | Montanaro E.; Artusi C.A.; Zibetti M.; Lopiano L. |
8 | COVID-19 and Parkinson's Disease: What We Know So Far? | 2021 | Artusi, Carlo Alberto; Romagnolo, Alberto; Ledda, Claudia; Zibetti, Maurizio; Rizzone, Mario Giorgio; Montanaro, Elisa; Bozzali, Marco; Lopiano, Leonardo |
9 | Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum | 2021 | Artusi, Carlo Alberto; Romagnolo, Alberto; Imbalzano, Gabriele; Montanaro, Elisa; Zibetti, Maurizio; Rizzone, Mario Giorgio; Lopiano, Leonardo |
10 | Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease | 2022 | Rizzone M.G.; Mancini F.; Artusi C.A.; Balestrino R.; Bonvegna S.; Fabbri M.; Imbalzano G.; Montanaro E.; Romagnolo A.; Zibetti M.; Lopiano L. |
11 | Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report | 2021 | Bozzali M.; Grassini A.; Morana G.; Zotta M.; Cabras S.; Romagnolo A.; Artusi C.A.; Montalenti E.; Rizzone M.G.; Garbossa D.; Montanaro E.; Cercignani M.; Lopiano L. |
12 | G325R GBA mutation in Parkinson's disease: Disease course and long-term DBS outcome | 2021 | Ledda C.; Artusi C.A.; Montanaro E.; Martone T.; Zibetti M.; Lopiano L. |
13 | Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential | 2020 | Artusi C.A.; Imbalzano G.; Sturchio A.; Pilotto A.; Montanaro E.; Padovani A.; Lopiano L.; Maetzler W.; Espay A.J. |
14 | Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study | 2021 | Beccuti G.; Guaraldi F.; Natta G.; Cambria V.; Prencipe N.; Cicolin A.; Montanaro E.; Lopiano L.; Ghigo E.; Zibetti M.; Grottoli S. |
15 | Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease | 2019 | Fabbri M, Zibetti M, Beccaria L, Merola A, Romagnolo A, Montanaro E, Ferreira JJ, Palermo S, Lopiano L. |
16 | Low frequency subthalamic stimulation and event-related potentials in Parkinson disease | 2021 | Romagnolo A.; Zibetti M.; Lenzi M.; Vighetti S.; Pongmala C.; Artusi C.A.; Montanaro E.; Imbalzano G.; Rizzone M.G.; Lopiano L. |
17 | Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 | 2021 | Balestrino, Roberta; Ledda, Claudia; Romagnolo, Alberto; Bozzali, Marco; Giulietti, Giovanni; Montanaro, Elisa; Rizzone, Mario; Zibetti, Maurizio; Artusi, Carlo Alberto; Lopiano, Leonardo |
18 | Narrative abilities in Parkinson's disease:A pilot study on italian-speaking patients treated with deep brain stimulation of the subthalamic nucleus | 2020 | FEDERICO FRAU, ELISA MONTANARO, MARIO SQUARTINI, MAURIZIO ZIBETTI, LEONARDO LOPIANO, RAFFAELLA SCARPA |
19 | Neurological comorbidities and COVID-19-related case fatality: A cohort study | 2021 | Romagnolo A.; Imbalzano G.; Artusi C.A.; Balestrino R.; Ledda C.; De Rosa F.G.; Riccardini F.; Montanaro E.; Bozzali M.; Rizzone M.G.; Zibetti M.; Lopiano L. |
20 | Neurological comorbidity and severity of COVID-19 | 2020 | Romagnolo A.; Balestrino R.; Imbalzano G.; Ciccone G.; Riccardini F.; Artusi C.A.; Bozzali M.; Ferrero B.; Montalenti E.; Montanaro E.; Rizzone M.G.; Vaula G.; Zibetti M.; Lopiano L. |